On Tuesday 20 February, Commissioner Vytenis Andriukaitis presented the draft regulation for joint European level clinical assessments, to the European Parliament's environment and public health committee. During the debate he particularly urged his co-legislators to step up their work in this regard.
The legislative proposal introduces “joint clinical assessments” for medicines and some of the most innovative medical and in-vitro devices (see EUROPE 11951). It stipulates that...